These differences in tumor burden were not a result of decreased tumor cell proliferation by manipulation of WAVE3 expression of posttranscriptional modification, as the number of viable cells between the control and WAVE3-deficient cells was similar (Fig. S1A, B). The gene discussed is WASF3; the disease is neoplasm.